The last decade has seen the emergence of literature documenting the effects and potential clinical benefits of slow breathing techniques, predominantly in disease states. The physiological effects of slow breathing in the healthy human, however, are yet to be comprehensively reviewed. Documented effects predominantly span the cardiovascular, autonomic, respiratory, endocrine and brain systems. The aim of this review is to provide a core definition of slow breathing, and summarise the major documented effects in healthy humans in order to form a knowledge base of the physiology and proposed mechanisms of slow breathing techniques upon which potential clinical applications can be discussed.

History of slow breathing {#s3a}
=========================

The act of controlling one's breath for the purpose of restoring or enhancing one's health has been practiced for thousands of years amongst Eastern cultures. For example, yogic breathing (pranayama) is a well-known ancient practice of controlled breathing, often performed in conjunction with meditation or yoga, for its spiritual and perceived health-enhancing effects \[[@C1], [@C2]\]. Various forms of pranayama exist, such as nostril breathing (double, single or alternate), abdominal breathing, forceful breathing and vocalised (chanting) breathing, which are performed at varying rates and depths \[[@C1], [@C2]\]. Yoga, and hence pranayama, was first introduced to the West in the late 1800s and its popularity rose in the mid-1900s. Breathing techniques have since become increasingly popular due to a rising interest in holistic and wellness approaches to healthcare. Their claimed health benefits and potential to treat a range of medical conditions has piqued the interest of the medical and scientific communities, and stimulated research into the area.

Since the 1990s, a system of breathing therapy developed within the Russian medical community by Konstantin Pavlovich Buteyko has made its way across several continents: the Buteyko method. K.P. Buteyko began treating patients with respiratory and circulatory diseases using breathing retraining in the 1950s and 1960s \[[@C3]\]. Buteyko and other clinicians who adopted his methods claimed success in treating a wide range of chronic disorders, though it was some time before the method spread to other countries \[[@C4]\]. Several clinical trials and Cochrane reviews have since investigated the effectiveness of the Buteyko method in the treatment of asthma, with more studies and consistent findings necessary in order to support reported promising results \[[@C5]--[@C10]\].

Review methods {#s4}
==============

Our objective was to provide a comprehensive review for respirologists, physiologists, and clinicians and researchers outside of the field. The review focuses on the respiratory system, cardiovascular system, cardiorespiratory unit and autonomic nervous system. Each section begins with a brief overview of the physiology of that system during normal respiration, followed by discussion of the researched physiological effects of slow breathing in healthy humans.

For the purpose of this review, we define slow breathing as any rate from 4 to 10 breaths per min (0.07--0.16 Hz). The typical respiratory rate in humans is within the range of 10--20 breaths per min (0.16--0.33 Hz).

We initially performed a Medline search *via* PubMed for articles reviewing or reporting on the effects of breathing at 4--10 breaths per min or 0.07--0.16 Hz in humans. Investigations of breathing outside of this range were excluded, as were those that incorporated respiratory load, continuous positive airway pressure machines or other breathing apparatus, and/or other breathing techniques and/or meditation, yoga, tai chi, exercise or dietary interventions, and so forth. The Medline search expanded during the writing of the manuscript to incorporate literature pertaining to the normal physiology of the respiratory, cardiovascular, cardiorespiratory and autonomic nervous systems, and other topics relevant to the review.

Physiology of slow breathing {#s5}
============================

Respiratory system {#s4a}
------------------

### Biomechanics of breathing {#s4a1}

The term "tidal breathing" defines normal respiration with a relatively constant rate and inspiratory/expiratory volumes (tidal volume). Tidal breathing is driven by a group of primary and accessory inspiratory muscles collectively named the "respiratory pump". The major respiratory muscle is the diaphragm, which, during normal inspiration, contracts and flattens, pushing on the abdomen, while the lower ribs are pushed upwards and outwards \[[@C11]\]. Coordinated contraction of the diaphragm, external intercostals, parasternal, sternomastoid and scalene muscles results in expansion of the ribcage and rising of the chest \[[@C12], [@C13]\]. This generates a transdiaphragmatic pressure (increased abdominal pressure and decreased thoracic pressure) resulting in a decrease in intrathoracic/intrapleural pressure and subsequent ventilation of the lungs upon which pulmonary gas exchange occurs *via* the alveoli across the transpulmonary pressure gradient \[[@C13], [@C14]\]. Expiration is generally passive, with the diaphragm returning to its domed resting configuration, causing the lungs to deflate and expel air. When breathing effort is increased, however, the expiratory muscles become active; these include abdominal muscles which pull the abdominal wall inwards when contracted, forcing the diaphragm to rise superiorly into the ribcage and deflate the lungs \[[@C15]\].

Studies of diaphragm movement and function claim that optimal respiration requires active control of the diaphragm, such that during inspiration, the lower ribs stay low and only expand laterally, while the abdomen expands instead of the chest \[[@C16]\]. Analysis of diaphragm movement during tidal breathing and breath holding using magnetic resonance imaging (MRI) and spirometry has reported a correlation between the degree of movement of the diaphragm and changes in lung volume: the greater the difference in diaphragm movement between inspiration and expiration, the greater the tidal volume \[[@C17]\]. Diaphragmatic breathing has also been shown to facilitate slow respiration. This was supported by a study in which healthy subjects trained in diaphragmatic breathing demonstrated slower respiratory rates and were more likely to achieve the study goal of 3--7 breaths per min than those subjects who breathed normally at a natural pace \[[@C18]\]. Another investigation of the diaphragm using MRI found that slow breathing was associated with greater diaphragm excursion in healthy humans, compared to patients with a chronic spinal pathology, and concluded that correct and balanced diaphragm performance helps to maintain abdominal pressure and "smooth" respiration \[[@C16]\].

### Ventilation and gas exchange {#s4a2}

The biomechanics of lung ventilation are carefully coordinated with blood oxygen, carbon dioxide and pH homeostasis. Minute ventilation is defined as respiratory rate multiplied by tidal volume; thus, to maintain minute ventilation, if respiratory rate is decreased, tidal volume must be increased. A decrease in respiratory rate alone would lead to hypercapnia and activation of chemoreceptors (predominantly central chemoreceptors located in the brain stem) that respond primarily by orchestrating a forced increase in respiration rate (hyperventilation) \[[@C19], [@C20]\]. Therefore, in order to maintain a decreased respiratory rate without disturbing respiratory homeostasis, tidal volume must be increased. Interestingly, it has been shown that controlled slow respiration at 6 breaths per min in healthy humans reduces the chemoreflex response to hypercapnia and hypoxia, compared with spontaneous respiration or controlled respiration at 15 breaths per min \[[@C21]\].

Physiological dead space is the sum of anatomical dead space (air that does not reach the alveoli) and alveolar dead space (air that enters poorly or nonperfused alveoli); increasing respiratory rate does not improve ventilation efficiency because dead space is increased \[[@C22]\]. Conversely, decreasing respiratory rate and increasing tidal volume has been shown to improve ventilation efficiency *via* alveolar recruitment and distension, thus reducing alveolar dead space \[[@C23]\]. A study of the effect of breathing rate on oxygen saturation and exercise performance has confirmed this by measuring arterial oxygen saturation during spontaneous respiration and respiration at 15, 6 and 3 breaths per min, during rest and during exercise, in healthy subjects and in chronic heart failure patients \[[@C24]\]. Slow respiration at 6 breaths per min was found to be optimal for improving alveolar ventilation and reducing dead space in both groups in terms of increased arterial oxygen saturation and ease and sustainability in terms of respiratory effort. Follow-up of patients with chronic heart failure who practiced slow breathing displayed increased exercise performance and motivation.

Cardiovascular system {#s4b}
---------------------

### Haemodynamic fluctuations {#s4b1}

The pumping of the heart and the flow of blood through the circulation are heavily influenced by various factors and events, such as oxygen demand, physical activity, stress, temperature and respiration \[[@C25]\]. In a steady-state system, the effects that respiration has on the cardiovascular system may first be discussed in terms of haemodynamics. During normal inspiration, the pressure gradient between the right heart and the systemic circulation is increased due to the decrease in intrathoracic/intrapleural pressure being transferred to the right atrium, which results in an increase in venous return, filling of the right atrium and right ventricular stroke volume \[[@C26], [@C27]\]. Meanwhile, pulmonary resistance increases, pulmonary venous return is decreased and blood pools in the pulmonary capillaries, leading to a reduction in filling of the left heart \[[@C26], [@C28]\]. This increased storage of blood in the right heart and pulmonary circulation leads to an increase in cardiac output that occurs during the next intrinsic heartbeat. During expiration, these changes are reversed.

The rate of respiration is known to affect haemodynamics. A study in which the arterial pulse (*via* heart rate and oscillometric arterial blood pressure) and peripheral resistance were analysed in healthy humans instructed to perform paced deep breathing at 20, 15, 10 and 6 breaths per min found that the rate of respiration affects the harmonics of the blood pressure pulse, which is related to the resistance of the peripheral vasculature, compliance of the aorta and hence venous return, such that slow respiration causes blood pulse fluctuations to synchronise with the heart beat rhythm \[[@C29]\]. Slow breathing towards a rate of 6 breaths per min has been said to result in increased venous return \[[@C30]\]. This is further augmented in diaphragmatic breathing due to the anatomical fact that the diaphragm is connected to and supports the heart, and provides passage for the aorta and the inferior vena cava \[[@C31]\]. Studies in diaphragmatic breathers have reported increased efficiency of venous return, maximally during slow respiration, due to diaphragmatic excursion enhancing the collapsibility of the inferior vena cava that occurs during normal inspiration \[[@C32], [@C33]\]. A recent study has also found that coupling of respiration and vasomotion (oscillations in vascular tone (*i.e*. arteriole diameter), which causes oscillations in capillary blood flow) becomes apparent when respiration is slowed, and at around 6 breaths per min, significantly greater coupling occurred in subjects with low initial blood oxygenation \[[@C34]\]. Speculation was made that vasomotion may become entrained and enhanced by slow respiration, particularly when there is room for improved blood oxygenation (*i.e*. tissue demands).

### Heart rate and blood pressure {#s4b2}

These respiratory phase-driven fluctuations in venous filling, stroke volume, cardiac output and peripheral blood flow contribute to fluctuations in heart rate and blood pressure \[[@C35], [@C36]\]. Under steady-state conditions, increased venous return during inspiration equals increased cardiac output and an increased heart rate, which would also affect arterial blood pressure \[[@C37]\]. It has long been known that the heart rate increases during inspiration while arterial blood pressure decreases, and *vice versa* during expiration \[[@C38]\].

While changes in the cardiovascular system can induce changes in respiration, the influence that respiration has on the cardiovascular system is reportedly stronger \[[@C25], [@C29], [@C30], [@C39], [@C40]\]. Studies in healthy humans have found that controlled slow breathing, particularly at 6 breaths per min, is associated with an increase in fluctuations of both blood pressure and heart rate, compared to breathing at a typical rate \[[@C21], [@C41], [@C42]\]. Some hypothesise that this reflects a buffering of respiratory-related haemodynamic fluctuations due to synchronisation of the pulsating blood flow to the rhythm of the heartbeat \[[@C29], [@C41]\]. Several studies have also reported significantly decreased mean blood pressure during controlled slow respiration, which would support this hypothesis \[[@C30], [@C41], [@C43], [@C44]\]. Studies in humans breathing at 6 breaths per min have also reported a tendency for heartbeats to cluster within the inspiratory phase \[[@C45]--[@C48]\]. Relationships between heart rate, blood pressure and respiration are known as cardiorespiratory coupling \[[@C40]\].

Cardiorespiratory unit {#s6}
======================

Heart rate variability and the baroreflex {#s5a}
-----------------------------------------

The instantaneous heart rate can be measured on an ECG recording as the time between beats: the R--R interval. Fluctuation of R--R intervals is a physiological occurrence known as heart rate variability (HRV). HRV and blood pressure fluctuations occur both randomly and rhythmically. Power spectral analysis of these fluctuations shows two significantly correlated rhythmic oscillations indicated by a peak at a frequency around 0.25 Hz (high frequency (HF)) and another at around 0.1 Hz (low frequency (LF)) \[[@C49], [@C50]\]. The HF oscillations coincide with the typical respiration frequency (*i.e*. 15 breaths per min, 0.25 Hz) and, hence, are related to the phasic effects of tidal respiration on the cardiovascular system (mechanical, haemodynamic and cardiorespiratory mechanisms), whereas LF oscillations are thought to correspond to cardiac feedback mechanisms that are slower than and independent of respiration \[[@C50]--[@C52]\].

The baroreceptor reflex (baroreflex) is a negative feedback mechanism involving stretch receptors, present primarily in the aortic arch and carotid sinuses, that monitor arterial blood pressure and respond to acute changes *via* central--neural--autonomic pathways, which we will discuss in more depth in later sections. Briefly, arterial baroreceptors are activated by an increase in blood pressure and fire signals *via* afferent nerves to the cardiovascular centre in the medulla oblongata, which relays fast parasympathetic efferent signals *via* the vagus nerve to the sinoatrial (SA) node to decrease heart rate, while sympathetic efferent signals relayed *via* the sympathetic chain in the thoracic spinal column to the heart and blood vessels are suppressed, adding to decreased heart rate, cardiac output and vasomotor tone (reviewed by W[ehrein]{.smallcaps} and J[oyner]{.smallcaps} \[[@C53]\]). Baroreceptor activity is reduced when blood pressure is low, resulting in the reverse effects. LF oscillations of arterial blood pressure (known as Mayer waves) are thought to represent the sympathetic arm of the baroreflex, which oscillates slower than respiration at 0.1 Hz \[[@C51], [@C54], [@C55]\]. The baroreflex is therefore tightly coupled to, perhaps even predominantly accountable for, LF HRV oscillations \[[@C51], [@C56]--[@C59]\].

HF HRV and baroreflex activity are influenced by the phasic effects of respiration, with the rate of respiration modulating the relationship between the HRV and blood pressure oscillations \[[@C60]\]. It has been indicated that slow breathing causes the pulse harmonics of blood flow (*i.e*. blood pressure oscillations) to synchronise with the rhythm of the heart \[[@C29]\]. Various studies have found that slow breathing increases amplitudes of blood pressure oscillations and HRV, and that this is particularly significant at a respiration rate of 6 breaths per min (0.1 Hz) \[[@C21], [@C61]--[@C64]\]. At 6 breaths per min, the LF HRV oscillations are said to be augmented by respiration \[[@C65], [@C66]\]. For example, a study in healthy males in which carotid baroreceptors were stimulated by neck suction during paced respiration found that the influence of the arterial baroreflex on the heart rate and blood pressure was enhanced during respiration at 6 breaths per min \[[@C41]\]. Furthermore, studies on the effects of respiratory phase time ratio have reported a tendency for baroreflex sensitivity and HRV amplitude to increase when the inspiration/expiration ratio is 1/1 during slow breathing at 0.1 Hz \[[@C67]--[@C69]\]. The rhythmic influence of phasic respiration on HRV is a physiological phenomenon known as respiratory sinus arrhythmia.

Respiratory sinus arrhythmia {#s5b}
----------------------------

Respiratory sinus arrhythmia (RSA) is HRV in synchrony with the phases of respiration, whereby R--R intervals are shortened during inspiration and lengthened during expiration \[[@C70], [@C71]\]. Typically, RSA has a frequency of 0.25 Hz (*i.e*. respiratory frequency) as reflected in the HF HRV oscillation peak. RSA frequency therefore changes with respiration rate and this is known to result in a shift in the phase difference between respiration and HRV (the heart rate response) and a change in the amplitude of HRV. This was first reported by A[ngelone]{.smallcaps} and C[oulter]{.smallcaps} \[[@C72]\] in an early continuous recording of RSA in a healthy human, which demonstrated that as the respiration rate was reduced, the phase difference was shortened, until at rate of 4 breaths per min, where HRV and inspiration/expiration were in exact phase; yet it was at 6 breaths per min (0.1 Hz), where the phase difference was at 90°, that maximisation of HRV amplitude was observed. Maximisation of RSA/HRV at around 6 breaths per min has since been confirmed by numerous studies \[[@C65], [@C73], [@C74]\]. This indicates cardiorespiratory system resonance and is hence referred to as a "resonant frequency effect" \[[@C72], [@C75]\]. At 0.1 Hz, RSA also resonates with the LF baroreflex integration frequency and Mayer waves \[[@C55]\]. Further investigations therefore suggest that both HRV (RSA) and baroreflex sensitivity are maximised when respiration is slowed to ∼6 breaths per min ([figure 1](#F1){ref-type="fig"}), though this resonant frequency does vary between individuals \[[@C25], [@C41], [@C52], [@C61], [@C62], [@C75]\]. Increasing tidal volume \[[@C36], [@C73], [@C76]\] and diaphragmatic breathing \[[@C18]\] have also been shown to significantly increase RSA, significantly more so at slower respiration rates. Conversely, numerous studies have reported decreased RSA with increasing respiration rate \[[@C72], [@C73], [@C77]\].

![Maximum HRV is typically observed at about a respiratory frequency of 6 breaths per min (0.1 Hz). Reproduced from \[[@C25]\] with permission from the publisher.](EDU-0098-2017.01){#F1}

RSA is thought to have a distinct physiological significance, though it has not been fully elucidated. Studies have indicated that one possible function of RSA is to enhance pulmonary gas exchange efficiency by entraining cardiovascular oscillations within the phases of respiration, thereby matching ventilation and perfusion to heart rate and hence pulmonary blood flow, and reducing physiologic dead space \[[@C45], [@C47], [@C48], [@C78], [@C79]\]. It has been further hypothesised that RSA has an intrinsic role in the resting state of the cardiorespiratory system, as improving pulmonary gas exchange efficiency would minimise energy expenditure, which is supported by the fact that RSA maximises during sleep, relaxation, slow, deep respiration, and when supine, and is reduced during exercise and states of anxiety (reviewed by H[ayano]{.smallcaps} and Y[asuma]{.smallcaps} \[[@C80]\]). An alternate hypothesis is that RSA minimises cardiac work while maintaining appropriate blood gas concentrations and that this is emphasised during slow, deep respiration \[[@C74], [@C81]\]. Studies have also pointed towards a role of RSA in buffering systemic blood flow oscillations resulting from respiratory-driven variations in venous filling and stroke volume of the left heart \[[@C29], [@C35]\]. The effect that slow breathing has on maximising RSA warrants discussion of its proposed mechanisms.

Mechanisms of RSA {#s5c}
-----------------

The precise mechanisms underlying RSA have been extensively explored, yet this topic remains relatively unsolved and under intense debate. The debate largely revolves around whether the baroreflex or a central respiratory centre predominantly generates RSA \[[@C82]\]. Settlement of this debate is impeded by the lack of consistency between experimental methods, study population heterogeneity and, hence, a lack of converging results, confounding variables, and the inability to truly determine cause and effect. Nonetheless, it is generally accepted that the genesis of RSA involves a network of central, peripheral and mechanical elements that are likely interacting bidirectionally and contributing synergistically to HRV \[[@C36], [@C38], [@C83]\].

The first layer of RSA generation involves mechanical factors such as changes in venous return, stroke volume and cardiac output that are driven by the respiratory swings in intrathoracic/intrapleural pressure, causing heart rate and blood pressure oscillations \[[@C52]\]. The baroreflex is also theorised to drive HRV in response to the respiratory swings in arterial blood pressure \[[@C25], [@C57], [@C74], [@C84]--[@C86]\]. Additional peripheral elements known to contribute to RSA include the peripheral chemoreflex \[[@C87]\], the Bainbridge reflex (atrial stretch receptors that respond to increases in blood volume during inspiration (when venous filling increases) by increasing heart rate \[[@C88], [@C89]\]) and the Hering--Breuer reflex (slowly adapting pulmonary stretch receptors activated by moderate to excessive lung inflation that invoke increased respiratory drive and heart rate) \[[@C71], [@C90], [@C91]\]. Augmentation of these mechanical elements and peripheral reflexes can be achieved by slow, deep breathing, which would contribute to the observed increases in RSA amplitude (reviewed by B[illman]{.smallcaps} \[[@C38]\]).

The central theory of RSA revolves around respiratory and cardiovascular centres in the medulla oblongata that converge to generate cardiorespiratory rhythms. The theory implicates a "neural pacemaker": oscillations of cardiorespiratory neuron activity that generate an intrinsic rhythm that regulates both systems \[[@C92]\]. These pacemaker neurons have been identified within the nucleus tractus solitarius (NTS) and the nucleus ambiguus, oscillations of which are reportedly in phase with respiratory phrenic nerve activity, and which are able to produce an intrinsic cardiorespiratory rhythm that regulates the heart rate *via* autonomic efferents along the vagus nerve (parasympathetic) and the cardiac sympathetic nerves to the SA node (reviewed by B[erntsen]{.smallcaps} *et al.* \[[@C70]\]). Whilst this neural pacemaker has an intrinsic rhythm, it is embedded in a complex network of neural pathways and inputs, including those of the mechanical and peripheral reflexes that are received by the neurons in the NTS \[[@C70], [@C90]\].

The proposal of a "respiratory gate" was an attempt to characterise the autonomic modulation of the heart beat by the cardiorespiratory centres. It was postulated that "inspiratory neurons" in the NTS constitute a gating mechanism, the opening and closing of which is synchronised to the phases of respiration \[[@C93]\]. Closing of the gate coincides with inspiration and pulmonary stretch receptor activation, while opening of the gate coincides with expiration, allowing autonomic efferents relaying activity from peripheral reflexes that accumulate within the NTS to flow into the nucleus ambiguus and be delivered to the heart \[[@C93]\]. This would support respiratory modulation of autonomic outflow as the primary generator of RSA \[[@C39]\].

Autonomic nervous system {#s5d}
------------------------

### Parasympathetic *versus* sympathetic {#s5d1}

Simplistically, it can be said that the two arms of the autonomic nervous system exert opposing control over the heart. Cardiac parasympathetic efferents are relayed *via* the vagus nerve and induce cardiac slowing *via* acetylcholine release, while sympathetic efferents are relayed *via* a network of nerves within the sympathetic chain of the thoracic spinal column and accelerate the heart rate *via* norepinephrine release \[[@C94]\]. Both systems display an intrinsic, tonic rhythm that is generated by a central neural mechanism; however, vagal activity is capable of eliciting a much faster influence on the heart than sympathetic activity, presumably due to faster signal transduction and acetylcholine-receptor kinetics, such that it is capable of delaying the immediate heartbeat and, hence, able to modulate the heart rate at higher frequencies, while cardiac sympathetic influence drops off at ∼0.1 Hz \[[@C70], [@C89], [@C95]\]. Furthermore, acetylcholine inhibits noradrenaline release and overshadows noradrenaline at the SA node; hence, parasympathetic activity is said to be the dominant arm of the autonomic nervous system, providing a homeostatic background level of control over the heart rate under resting conditions \[[@C95]--[@C98]\]. Sympathetic activity is presumably minimal or absent under resting conditions in healthy humans, whereas it is high in various disease states, and in healthy humans during exercise, and physical and mental perturbations \[[@C51], [@C94]\].

HRV is therefore largely a product of parasympathetic and sympathetic nervous system activity \[[@C38]\]. HF HRV oscillations are thought to be predominantly parasympathetically mediated, while LF HRV oscillations are thought to be both sympathetically and parasympathetically mediated, depending on the circumstances as mentioned earlier \[[@C49], [@C99]\]. HRV is therefore regarded as a qualitative index of "sympathovagal balance", reflecting the weight of parasympathetic *versus* sympathetic autonomic control, whereby a higher LF/HF HRV ratio reflects sympathetic dominance and a lower ratio reflects parasympathetic dominance \[[@C100]--[@C102]\].

### Respiratory modulation of autonomic outflow {#s5d2}

Both arms of the autonomic nervous system are under the control of the central respiratory centres, where autonomic drive from the reflex mechanisms and the lung stretch receptors converges. Autonomic outflows are inhibited during inspiration and disinhibited during expiration: the respiratory gate theory \[[@C39], [@C52], [@C93]\]. Respiratory phase influence on cardiovagal activity is thought to be far more significant; however, due to a more direct central--neural driving mechanism, and the speed of parasympathetic signal transduction and effect that would allow for heart rate modulation at all respiratory frequencies \[[@C70], [@C89]\]. Sympathetic bursts do occur when the gate is open during expiration, however, there is a much greater response lag compared to parasympathetic action, and they are also less effective the greater the vagal activity due to suppression of noradrenaline release and effect \[[@C39], [@C95], [@C96], [@C98]\]. Adding to this, the observed correlation between phasic parasympathetic vagal activity ("vagal tone") with respiratory phase-related HRV oscillations underpins the hypothesis that RSA is largely a vagal phenomenon \[[@C71], [@C103]\].

Using power spectral analysis corrected for respiratory influence, the effect of respiration rate on autonomic activity can be assessed using LF/HF power and time domain indices \[[@C65]\]. Using this method, C[hang]{.smallcaps} *et al.* \[[@C42]\] reported a shift towards parasympathetic balance and an increase in vagal activity in healthy humans who breathed at 8 breaths per min, as opposed to 12 and 16 breaths per min. Similarly, Z[hang]{.smallcaps} *et al.* \[[@C103]\] performed an investigation in healthy humans breathing at 8 (slow), 12 (average) and 18 (fast) breaths per min using time domain analysis to characterise the respiration response curves of vagal activity. They found that slow breathing augmented vagal power by entraining vagally induced cardiac resetting to the phases of respiration \[[@C97]\]. It has also been shown that during controlled, slow, deep breathing, the respiratory phase modulation of sympathetic activity is stronger, such that more complete inhibition is observed during early inspiration to mid expiration \[[@C104]\]. It has been suggested that in order to achieve a long-term shift towards parasympathetic dominance, prolonged practice of slow breathing is necessary, as was observed in healthy humans who practiced slow breathing regularly for 3 months \[[@C105]\].

T[aylor]{.smallcaps} *et al.* \[[@C76]\] examined the effects of sympathetic blockade on RSA in healthy humans at varying respiration rates (15--3 breaths per min) and found that RSA was enhanced when cardiac sympathetic activity was blocked at all respiratory frequencies. Their results also indicated that tonic vagal activity is constant across respiratory frequencies, to which they speculated that during fast breathing, less acetylcholine is released as expiration is shortened; thus, RSA is reduced. Conversely, whilst at resonant frequency (6 breaths per min), acetylcholine release and hydrolysis is optimised; hence, RSA is maximised. Further to this point, W[ang]{.smallcaps} *et al.* \[[@C67]\] observed a tendency for increased HRV at 6 breaths per min when the inspiration/expiration ratio was 1/1, and based their explanation on optimal acetylcholine release and hydrolysis.

Conversely, researchers have postulated that at 6 breaths per min, while sympathetic activity is not necessarily changed, sympathetic bursts may also contribute to HRV, probably due to baroreflex and Mayer wave integration at this respiratory frequency \[[@C65], [@C70]\]. In the study by Z[hang]{.smallcaps} *et al.* \[[@C103]\], whilst they observed an increase in vagal power with slow breathing, sympathetic power did not significantly change; however, a change in the pattern of sympathetic bursts within breaths was observed (also reported by K[oizumi]{.smallcaps} *et al.* \[[@C96]\], S[eals]{.smallcaps} *et al.* \[[@C104]\] and L[imberg]{.smallcaps} *et al.* \[[@C106]\]). On a similar note, V[idigal]{.smallcaps} *et al.* \[[@C107]\] conducted an investigation into the effects of slow respiration (6 breaths per min) on autonomic response to postural manoeuvre. Slow breathing improved cardiac sympathetic and parasympathetic responsiveness to physical perturbations, which they suggested may be a result of augmented baroreflex sensitivity due to increased (initial) parasympathetic tone, and synchronisation of sympathetic and parasympathetic systems at 6 breaths per min. Therefore, it is not to be mistaken that slow breathing practice should minimise sympathetic activity, but rather, that it appears capable of achieving optimal sympathovagal balance, and enhancing autonomic reactivity to physical and mental stress.

Discussion {#s7}
==========

The physiological effects of slow breathing are indeed vast and complex. A simplified model of the respiratory--central nervous system--cardiovascular interaction network is presented in [figure 2](#F2){ref-type="fig"} \[[@C108]\]. From this review, it can be seen that the breathing pattern, as defined by respiratory rate, tidal volume, diaphragmatic activation, respiratory pauses and passive *versus* active expiration, has a profound effect not only on respiration efficiency but also extending to cardiovascular function and autonomic function, where the effects are bidirectional. A summary of the major effects of slow breathing (evidenced or theorised) discussed in this review is presented in [table 1](#TB1){ref-type="table"}.

![Simplified model of cardiorespiratory control showing coupling between respiratory and cardiovascular systems. τ: circulatory delay; ILV: instantaneous lung volume; HR: heart rate; CNS: central nervous system; SAP: systolic arterial pressure; DAP: diastolic arterial pressure. Reproduced from \[[@C108]\] with permission from the publisher.](EDU-0098-2017.02){#F2}

###### 

Documented effects of slow breathing in the healthy human body as referenced throughout this review

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Respiratory**                Generally coincides with increased tidal volume and may enhance diaphragmatic excursion \[16, 18\]\
                                 Enhances ventilation efficiency and arterial oxygenation *via* alveolar recruitment, and distension and reduction of alveolar dead space \[23, 24\]\
                                 Moderates chemoreflex sensitivity \[21\]
  ------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------
  **Autonomic nervous system**   Increases vagal activity (vagal tone) \[42, 103\]\
                                 Shift towards parasympathetic dominance \[42, 105\]\
                                 Augments vagal power (entrainment of cardiac resetting by vagus to respiration phases) \[97, 103\]\
                                  *Optimises acetylcholine release and hydrolysis at SA node \[67, 76\]*\
                                 Enhances phasic modulation of sympathetic activity \[104, 106\]\
                                 Improves autonomic responsiveness to physical perturbations (*i.e*. standing) \[107\]\
                                  *Optimises sympathovagal balance \[107\]*

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Hypotheses and plausible speculations are italicised.

Implications {#s6a}
------------

Variations in respiratory parameters can occur within the normal population in the absence of respiratory diseases; however, traditional medicine has not attempted to define what may constitute optimised respiration within the normal population, and given the profound effect on vagal tone, what constitutes "autonomically optimised respiration". Perhaps it is time to refine a breathing technique that optimises ventilation, gas exchange and arterial oxygenation, maximises vagal tone, maintains parasympathetic--sympathetic balance and optimises the amount of cardiorespiratory reserve that could be called upon in times of intense physical or mental stress or activity. According to the studies reviewed here, "autonomically optimised respiration" would appear to be in the band of 6--10 breaths per min, with an increased tidal volume that is achieved by diaphragmatic activation. Although not reviewed here, nasal breathing is also considered an important component of optimised respiration \[[@C109], [@C110]\]. This is easily achievable in most individuals with simple practise and there is yet to appear in the literature any documented adverse effects of respiration in the 6--10 breaths per min range. Controlled, slow breathing appears to be an effective means of maximising HRV and preserving autonomic function, both of which have been associated with decreased mortality in pathological states and longevity in the general population \[[@C41], [@C111]--[@C119]\].

Future research directions {#s6b}
--------------------------

Specific physiological variables have been examined primarily during short-term performance of spontaneous and controlled slow breathing in a controlled environment, while recordings during sustained practice of slow breathing are scarce. Of great scientific interest is the effect of long-term practice of slow breathing. Research could subsequently expand into whether controlled slow breathing can optimise physiological variables in pathological conditions (not limited to the respiratory system). A hierarchy of research will provide a foundation upon which any therapeutic claims can be tested and validated.
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